Filter News
Area of Research
- (-) National Security (3)
- (-) Neutron Science (11)
- Advanced Manufacturing (1)
- Biology and Environment (17)
- Clean Energy (17)
- Computational Biology (1)
- Computer Science (1)
- Fusion and Fission (2)
- Isotope Development and Production (1)
- Isotopes (4)
- Materials (8)
- Materials for Computing (4)
- Nuclear Science and Technology (6)
- Supercomputing (38)
News Topics
- (-) Coronavirus (10)
- (-) Exascale Computing (1)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (8)
- Advanced Reactors (2)
- Artificial Intelligence (18)
- Big Data (8)
- Bioenergy (9)
- Biology (9)
- Biomedical (13)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (5)
- Composites (1)
- Computer Science (31)
- Cybersecurity (19)
- Decarbonization (4)
- Energy Storage (8)
- Environment (13)
- Fossil Energy (1)
- Frontier (2)
- Fusion (2)
- Grid (6)
- High-Performance Computing (6)
- Machine Learning (15)
- Materials (16)
- Materials Science (24)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (11)
- National Security (34)
- Neutron Science (99)
- Nuclear Energy (7)
- Partnerships (4)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (8)
- Security (12)
- Simulation (1)
- Summit (7)
- Sustainable Energy (4)
- Transportation (7)
Media Contacts
How did we get from stardust to where we are today? That’s the question NASA scientist Andrew Needham has pondered his entire career.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Laboratory Director Thomas Zacharia presented five Director’s Awards during Saturday night's annual Awards Night event hosted by UT-Battelle, which manages ORNL for the Department of Energy.
When the COVID-19 pandemic stunned the world in 2020, researchers at ORNL wondered how they could extend their support and help
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Researchers from NASA’s Jet Propulsion Laboratory and Oak Ridge National Laboratory successfully created amorphous ice, similar to ice in interstellar space and on icy worlds in our solar system. They documented that its disordered atomic behavior is unlike any ice on Earth.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.